Faïza Lamine

2.6k total citations · 2 hit papers
22 papers, 1.9k citations indexed

About

Faïza Lamine is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Faïza Lamine has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Faïza Lamine's work include Diabetes Management and Research (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Faïza Lamine is often cited by papers focused on Diabetes Management and Research (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Faïza Lamine collaborates with scholars based in Switzerland, Tunisia and France. Faïza Lamine's co-authors include Gerasimos P. Sykiotis, Montserrat Fraga, John A. Thompson, Camillo Ribi, Keyvan Shabafrouz, Thierry Küntzer, Michel Obéid, Solange Peters, Michel H. Maillard and Olivier Michielin and has published in prestigious journals such as Nature Reviews Clinical Oncology, Frontiers in Pharmacology and BMJ Open.

In The Last Decade

Faïza Lamine

22 papers receiving 1.9k citations

Hit Papers

Adverse effects of immune-checkpoint inhibitors: epidemio... 2019 2026 2021 2023 2019 2024 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
    2019 1.5k citations Filipe Martins, Sofiya Latifyan et al. Nature Reviews Clinical Oncology profile →
  2. Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services
    2024 43 citations Kim Dao, Svetlana Shechtman et al. BMJ Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faïza Lamine Switzerland 10 1.2k 468 349 253 186 22 1.9k
Michael G. Fradley United States 28 1.4k 1.1× 432 0.9× 497 1.4× 410 1.6× 313 1.7× 139 3.5k
Stéphane Éderhy France 27 1.3k 1.0× 239 0.5× 525 1.5× 449 1.8× 332 1.8× 116 3.0k
Joachim Alexandre France 24 918 0.7× 176 0.4× 358 1.0× 357 1.4× 175 0.9× 98 2.1k
Ye Guo China 28 1.0k 0.8× 264 0.6× 393 1.1× 684 2.7× 279 1.5× 217 2.3k
Mathilde Jalving Netherlands 25 1.0k 0.8× 194 0.4× 466 1.3× 927 3.7× 448 2.4× 102 2.4k
Marc Thill Germany 22 1.1k 0.9× 201 0.4× 507 1.5× 253 1.0× 330 1.8× 163 2.3k
N. Simon Tchekmedyian United States 27 1.5k 1.2× 412 0.9× 625 1.8× 319 1.3× 359 1.9× 55 2.6k
Peter Krippl Austria 27 665 0.5× 161 0.3× 301 0.9× 787 3.1× 137 0.7× 59 1.9k
Peter Canney United Kingdom 25 1.3k 1.0× 121 0.3× 472 1.4× 359 1.4× 336 1.8× 77 2.6k
Saraswati Pokharel United States 21 462 0.4× 716 1.5× 234 0.7× 799 3.2× 311 1.7× 58 2.1k

Countries citing papers authored by Faïza Lamine

Since Specialization
Citations

This map shows the geographic impact of Faïza Lamine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faïza Lamine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faïza Lamine more than expected).

Fields of papers citing papers by Faïza Lamine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faïza Lamine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faïza Lamine. The network helps show where Faïza Lamine may publish in the future.

Co-authorship network of co-authors of Faïza Lamine

This figure shows the co-authorship network connecting the top 25 collaborators of Faïza Lamine. A scholar is included among the top collaborators of Faïza Lamine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faïza Lamine. Faïza Lamine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dao, Kim, Svetlana Shechtman, Corinna Weber‐Schoendorfer, et al.. (2024). Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services. BMJ Open. 14(4). e083550–e083550. 43 indexed citations breakdown →
2.
Dotta-Celio, Jennifer, Isabella Locatelli, Grégoire Wuerzner, et al.. (2024). The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study. Frontiers in Pharmacology. 15. 1294436–1294436. 3 indexed citations
3.
Lamine, Faïza, et al.. (2023). 5-Fluorouracil-associated severe hypertriglyceridaemia with positive rechallenge. BMJ Case Reports. 16(12). e254871–e254871. 2 indexed citations
4.
Zanchi, Anne, Andreas Werner Jehle, Faïza Lamine, et al.. (2023). Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss Medical Weekly. 153(1). 40004–40004. 7 indexed citations
5.
Dotta-Celio, Jennifer, Isabella Locatelli, Grégoire Wuerzner, et al.. (2021). Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS). JMIR Research Protocols. 10(3). e25966–e25966. 6 indexed citations
6.
7.
Martins, Filipe, Sofiya Latifyan, Gerasimos P. Sykiotis, et al.. (2019). Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nature Reviews Clinical Oncology. 16(9). 563–580. 1544 indexed citations breakdown →
8.
9.
Lamine, Faïza, et al.. (2019). Défis dans la prise en charge du diabète en hémodialyse chronique. Revue Médicale Suisse. 15(653). 1132–1139. 1 indexed citations
10.
Lamine, Faïza, et al.. (2018). Subclinical hypothyroidism: new trials, old caveats. HORMONES. 17(2). 231–236. 7 indexed citations
11.
Cossu, Giulia, Roy Thomas Daniel, Katarzyna Pierzchała, et al.. (2018). Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management. Pituitary. 22(1). 79–88. 36 indexed citations
12.
Lamine, Faïza, et al.. (2018). A case of benign insulinoma successfully treated with endoscopic ultrasound guided radiofrequency ablation. Endocrine Abstracts. 12 indexed citations
13.
Bongiovanni, Massimo, Georgios Papadakis, Laura Marino, et al.. (2018). The Bethesda System for Reporting Thyroid Cytopathology Explained for Practitioners: Frequently Asked Questions. Thyroid. 28(5). 556–565. 16 indexed citations
14.
Lamine, Faïza, et al.. (2016). Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs. Swiss Medical Weekly. 146(708). w14282–w14282. 10 indexed citations
15.
Chihaoui, Mélika, et al.. (2016). Bone Mineral Density in Sheehan's Syndrome; Prevalence of Low Bone Mass and Associated Factors. Journal of Clinical Densitometry. 19(4). 413–418. 11 indexed citations
16.
Grouzmann, Eric & Faïza Lamine. (2013). Determination of catecholamines in plasma and urine. Best Practice & Research Clinical Endocrinology & Metabolism. 27(5). 713–723. 58 indexed citations
17.
Chihaoui, Mélika, et al.. (2012). Syndrome de McCune-Albright associé à un diabète sucré. Archives de Pédiatrie. 19(3). 282–284. 1 indexed citations
18.
19.
Lamine, Faïza, et al.. (2008). Déficit en GH par interruption de la tige pituitaire dans l’anémie de Fanconi. Annales d Endocrinologie. 69(1). 63–68. 3 indexed citations
20.
Lamine, Faïza, et al.. (2006). Food intake and high density lipoprotein cholesterol levels changes during ramadan fasting in healthy young subjects.. PubMed. 84(10). 647–50. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael G. Fradley Breakdown of academic impact, for papers by Stéphane Éderhy Breakdown of academic impact, for papers by Joachim Alexandre Breakdown of academic impact, for papers by Ye Guo Breakdown of academic impact, for papers by Mathilde Jalving Breakdown of academic impact, for papers by Marc Thill Breakdown of academic impact, for papers by N. Simon Tchekmedyian Breakdown of academic impact, for papers by Peter Krippl Breakdown of academic impact, for papers by Peter Canney Breakdown of academic impact, for papers by Saraswati Pokharel
Rankless by CCL
2026